Aspen Pharmacare Holdings Limited (APNHY)
USD 8.5
(-1.85%)
USD 8.5
(-1.85%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 44.7 Billion | 2.29 Billion | 2.53 Billion | 2.45 Billion | 2.14 Billion | 2.5 Billion |
| Cost of Revenue | 25.25 Billion | 1.26 Billion | 1.38 Billion | 1.35 Billion | 1.1 Billion | 1.23 Billion |
| Gross Profit | 19.45 Billion | 1.02 Billion | 1.15 Billion | 1.09 Billion | 1.03 Billion | 1.27 Billion |
| Operating Expenses | 12.41 Billion | 516.8 Million | 545.81 Million | 575.83 Million | 552.17 Million | 605.47 Million |
| Selling, General and Administrative Expenses | 10.1 Billion | 516.8 Million | 545.81 Million | 575.83 Million | 552.17 Million | 605.47 Million |
| Research and Development Expenses | 162 Million | 214 Million | 433 Million | 260 Million | 195 Million | 211 Million |
| Other Expenses | 2.15 Billion | 4.86 Billion | - | - | - | - |
| Cost and Expenses | 37.7 Billion | 1.78 Billion | 1.93 Billion | 1.92 Billion | 1.66 Billion | 1.83 Billion |
| Operating Income | 6.99 Billion | 504.53 Million | 605.79 Million | 523.6 Million | 486.94 Million | 665.88 Million |
| Interest Expense | 2.22 Billion | 67.29 Million | 46.05 Million | 78.49 Million | 111.88 Million | 159.1 Million |
| Income Tax Expense | 1.31 Billion | 74.66 Million | 108.13 Million | 77.26 Million | 52.21 Million | 47.3 Million |
| Earnings before Tax | 5.71 Billion | 368.82 Million | 534.38 Million | 388.53 Million | 267.94 Million | 165.73 Million |
| Net Income | 4.4 Billion | 294.15 Million | 426.24 Million | 286.03 Million | 310.07 Million | 149.23 Million |
| Earnings Per Share Basic | 9.91 | 0.66 | 0.94 | 0.63 | 0.68 | 0.33 |
| Earnings Per Share Diluted | 9.91 | 0.66 | 0.94 | 0.63 | 0.68 | 0.33 |
| Weighted Average Shares Outstanding | 444.22 Million | 444.2 Million | 453 Million | 456.5 Million | 456.5 Million | 456.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 444.2 Million | 444.2 Million | 453 Million | 456.5 Million | 456.5 Million | 456.5 Million |
| Gross Margin | 0.44 | 0.45 | 0.45 | 0.45 | 0.48 | 0.51 |
| EBIT Margin | 0.22 | 0.26 | 0.28 | 0.26 | 0.27 | 0.30 |
| Profit Margin | 0.10 | 0.13 | 0.17 | 0.12 | 0.14 | 0.06 |
| EBITDA | 9.91 Billion | 9.66 Billion | 10.61 Billion | 8.84 Billion | 7.45 Billion | 5.85 Billion |
| Earnings Before Tax Margin | 0.16 | 0.22 | 0.24 | 0.21 | 0.23 | 0.27 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 11.78 Billion | 11.78 Billion | 10.57 Billion | 10.57 Billion | 2.29 Billion | 10.77 Billion |
| Cost of Revenue | 6.73 Billion | 6.73 Billion | 5.91 Billion | 5.91 Billion | 1.26 Billion | 5.82 Billion |
| Gross Profit | 5.05 Billion | 5.05 Billion | 4.65 Billion | 4.65 Billion | 1.02 Billion | 4.95 Billion |
| Operating Expenses | 3.3 Billion | 3.3 Billion | 2.9 Billion | 2.92 Billion | 516.8 Million | 3.08 Billion |
| Selling, General and Administrative Expenses | 2.55 Billion | 2.55 Billion | 2.49 Billion | 2.49 Billion | - | 2.38 Billion |
| Research and Development Expenses | 81 Million | 81 Million | - | - | - | 107 Million |
| Other Expenses | 671 Million | 671 Million | 407 Million | - | - | - |
| Cost and Expenses | 10.03 Billion | 10.03 Billion | 8.82 Billion | 8.84 Billion | 1.78 Billion | 8.91 Billion |
| Operating Income | 1.74 Billion | 1.74 Billion | 1.75 Billion | 1.75 Billion | 504.53 Million | 2.51 Billion |
| Interest Expense | - | - | 51.29 Million | - | 67.29 Million | 45.47 Million |
| Income Tax Expense | 358 Million | 358 Million | 297 Million | 297 Million | 74.66 Million | 351.5 Million |
| Earnings before Tax | 1.4 Billion | 1.4 Billion | 1.45 Billion | 1.45 Billion | 368.82 Million | 1.62 Billion |
| Net Income | 1.04 Billion | 1.04 Billion | 1.15 Billion | 1.15 Billion | 294.15 Million | 1.27 Billion |
| Earnings Per Share Basic | 2.35 | 2.35 | 2.60 | 2.60 | - | 2.87 |
| Earnings Per Share Diluted | 2.35 | 2.35 | 2.60 | 2.60 | - | 2.87 |
| Weighted Average Shares Outstanding | 444.12 Million | 444.12 Million | 444.31 Million | 444.31 Million | 444.2 Million | 444.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 444.1 Million | 444.1 Million | 444.3 Million | 444.3 Million | 444.2 Million | 444.2 Million |
| Gross Margin | 0.43 | 0.43 | 0.44 | 0.44 | 0.45 | 0.46 |
| EBIT Margin | 0.25 | 0.25 | 0.21 | 0.21 | - | 0.25 |
| Profit Margin | 0.09 | 0.09 | 0.11 | 0.11 | 0.13 | 0.12 |
| EBITDA | 2.92 Billion | 2.92 Billion | 2.22 Billion | 2.22 Billion | - | 2.71 Billion |
| Earnings Before Tax Margin | 0.15 | 0.15 | 0.17 | 0.17 | 0.22 | 0.23 |
PIONAGR
DCAL
7744
BYCRF
CENTRUM
ATEAY